EUVIMEDEUVIMED entdecken
Crossref

Beyond HNA-1: The anti-HNA-3 autoantibody as a protagonist in autoimmune neutropenia

Renato Cerqueira, Elyse Moritz, Josefina A P Braga, Akemi K Chiba, João B Pesquero, José O Bordin

Immunology Letters · 2026

DOI: 10.1016/j.imlet.2025.107095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology Letters, 2026. Verfasst von Renato Cerqueira und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Oncology, Universidade Federal de São Paulo, Brazil. Electronic address: cerqueira.renato@unifesp.br. Hauptthemen laut MEDLINE: Autoantibodies, Neutropenia, Autoimmune Diseases, Isoantigens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Coordination for the improvement of Higher Education Personnel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Autoimmune neutropenia (AIN), a common cause of chronic neutropenia, has been categorized as primary (pAIN) and secondary (sAIN). This study investigates the specificity of anti-HNA autoantibodies in both types. MATERIALS AND METHODS: A prospective cohort study of 85 chronic neutropenia patients included those with detectable anti-HNA autoantibodies. Anti-HNA was assessed using granulocyte agglutination (GAT), granulocyte immunofluorescence (GIFT), and LABScreen Multi Kit (LSM). Molecular analysis was performed to assess HNA expression. RESULTS: Of 85 patients, 7 had pAIN and 8 had sAIN. All pAIN patients exhibited only anti-HNA-1, while anti-HNA-3 was found in 3/8 sAIN patients. All patients with anti-HNA-3 tested positive in LSM; one was positive in both GAT and GIFT. DISCUSSION: While anti-HNA-3 has been described exclusively as an alloantibody, this is the first report of anti-HNA-3 as an autoantibody in AIN. CONCLUSION: Anti-HNA-3 autoantibody is associated only with sAIN, suggesting distinct mechanisms in pAIN and sAIN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesNeutropeniaAutoimmune DiseasesIsoantigensHumansMaleFemaleMiddle AgedAdultAgedProspective StudiesYoung Adult

Stichwörter der Autor:innen

Autoimmune neutropeniaAutoimmunityCTL2HNA-3

Substanzen

AutoantibodiesIsoantigensneutrophil-specific antigen NA1, human

Autor:innen und Institutionen

  • Department of Clinical and Experimental Oncology, Universidade Federal de São Paulo, Brazil. Electronic address: cerqueira.renato@unifesp.br.
  • Department of Clinical and Experimental Oncology, Universidade Federal de São Paulo, Brazil.
  • Department of Pediatrics, Universidade Federal de São Paulo, Brazil.
  • Department of Biophysics, Universidade Federal de São Paulo, Brazil.

Förderung

  • Coordination for the improvement of Higher Education Personnel

Zitieren

APA

Cerqueira, R., Moritz, E., Braga, J. A. P., Chiba, A. K., Pesquero, J. B., & Bordin, J. O. (2026). Beyond HNA-1: The anti-HNA-3 autoantibody as a protagonist in autoimmune neutropenia. Immunology Letters. https://doi.org/10.1016/j.imlet.2025.107095

Vancouver

Cerqueira R, Moritz E, Braga JAP, Chiba AK, Pesquero JB, Bordin JO. Beyond HNA-1: The anti-HNA-3 autoantibody as a protagonist in autoimmune neutropenia. Immunology Letters. 2026. doi:10.1016/j.imlet.2025.107095

BibTeX
@article{Cerqueira2026,
  author = {Cerqueira, Renato and Moritz, Elyse and Braga, Josefina A P and Chiba, Akemi K and Pesquero, João B and Bordin, José O},
  title = {Beyond HNA-1: The anti-HNA-3 autoantibody as a protagonist in autoimmune neutropenia},
  journal = {Immunology Letters},
  year = {2026},
  doi = {10.1016/j.imlet.2025.107095}
}
Kostenlos starten →